Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

NCT05377905 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma
Skin Cancers - Squamous Cell Carcinoma

Interventions

DRUG: Microneedle Array Doxorubicin (MNA-D)

Sponsor

Falo, Louis, MD

Collaborators

[object Object]